Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
There are many formulations...one with vitamin c, etc...either way I would protect my patent if someone was saying they were going to use it.
ITV-1 was a different agreement (not ipf) that came after the merger...Rosetta has been selling Enzoimmune prior to IPF Immune being announced. Rosetta continues to ship the US and Harry does nothing about it. Even other OTC ticker has stated on bringing their IPF product as they had rights to it, and when brought to his attention, he didn't act as one would if someone was stealing from them.
Well, Harry has licensed his IPF to Rosetta Lifecare for Enzoimmune which is outside of Enzolytics/Virogentics exclusive rights from Zhabilov Trust...not sure how Harry has been doing this for years while excluding the benefits to Enzolytics or the shareholders.
Is there criteria that the Company has to meet to keep licensing agreements?
Anyone ask Steve or Harry on status of that?
Not sure...but ive talked to Harry a few times to make sure he understands that AI and mAbs are why most of us are invested...we shall see what happens next.
That was also before Harry held a vote and removed Charles as CEO...I would reach out to Harry as many have already.
I just saw his post...thanks
What discord? I haven't seen this...
There are 2 AI platforms...Chandradrishti which is under BGEN and then there is Enzolytics AI that is with Enzolytics as mentioned in January's PR.
Here you go I-glow...this is Dr Khalpey talking, not Enzolytics "big talk" as you make it out to be.
$ENZC #ENZC
— Mark FTW 🇺🇸 (@MarkFTW7) March 20, 2024
Listen to @ZainKhalpey discuss @KhalpeyLab working with @IBM and @Enzolytics
Great work @ZainKhalpey and @DrGauravChandra 👏 🙌#AI #mAbs #Healthcare
Full video in Dr Zains tweet below. https://t.co/9FzFoDhWtz pic.twitter.com/kNrGKbg6MZ
There are two different AI platforms that have different applications, there is ENZCs Enzolytics AI and BGENs Chandradrishti platforms.
There are two different partnerships...one with Biogenysis (PRd Sept 2023) and one with Enzolytics (Jan 2024).
GLTA!
Listen to Dr Zain Khalpey discuss working with #IBM and #Enzolytics
https://x.com/MarkFTW7/status/1770576986491990182?t=fY4rs_4i2b1ACtEBI1h_jA&s=08
Would you like them to dilute to build up their office staff just for fun? Cause that sounds like a terrible business strategy for them and for investors...but good luck man.
Except for that little SAGA thing that has kept both BGEN and VIRO quiet...
January PR was about Enzolytics updates, it was not about BGEN or VIRO which are the subs that were going to SAGA.
How was clone 3 "pumped" when BioClonetics didn't go public until end of 2020 when they merged with Enzolytics?
Also they are working on their Recombinant Clone 3, which is what Samsung has produced after the in vitro studies and they then completed efficacy studies using CHO. This has been spoken in their filings and PRs for anyone who reads the news.
Iran? Not sure how a Ukrain flag colors can be confused with Iran, but okay if you say so...
What about my post a few days back...I said glad Harry isn't the CEO? Or I wasn't referring to ITV-1 patent...you seem to want to discuss something but you are going about this in an odd manner.
Anyway this is my last post cause Ihub. GLTA.
No idea what you are talking about and did not answer my question...
Thanks for your random comment, I suppose
Please share my most recent ihub pump post...I would like to see your definition of pumping, cause you don't seem to understand what constitutes pumping vs supporting/advocating.
I'm not talking about ITV-1 nor its patents from Harry, as it has already had some trials and is not why most ppl invested into this stock.
Harry has a terrible past and I'm glad he was removed as CEO in late 2020.
Because animal studies come first, the milestone they have to meet...then they will license out to Pharna to do the clinical trials...this has been clearly stated to the shareholders.
They are a small biotech company not a big pharmaceutical company. Patent their tech and license out is how this play works for those who actually paid attention.
My post was a few short sentences...much shorter than your random and pointless reply to me.
Why stay on a board of a stock you don't believe in...seems quite odd to punish yourself that way. Good luck and hope you get some positivity coming your way.
Now I'm down to 1 post for the day.
Clearly you don't understand context...ENZC server is free on the discord application which is also free. Your reading comprehension seems to be lacking.
You replied to my comment with additional comments about another post topic...you should reply to that post with your comment.
You can dm me if you have a question specifically about the pps 3 years ago...I can share what's on yahoo finance to review if that helps you.
And the server that is relevant is the ENZC discord which is free...so these "other" servers aren't relevant to this board and therfore should remain off the board.
Now I'm down to 1 more post as I had to respond to this.
Discord subscriptions? Showing you are full of shit, which is apparent as usual. But this is beyond pathetic.
Discord is a free platform for ppl to use.
That's odd...I have extended family and friends who have aren't invested that are glad I introduced them to the Immune Booster.
It's a great product and has kept many ppl from getting sick and has helped many more overcome symptoms quite quickly.
Take another booster for all I care...IPF Immune has proven itself in my household.
Why would one buy on Amazon when you can buy IPF at Virogenticsinc.com and get 15% off that was announced last month?
https://clinicalcenter.nih.gov/meet-our-doctors/cgrady.html
Updated last month, she's listed on NIH website as:
Christine Grady, MSN, PhD
Chief, Bioethics
Head, Section on Human Subjects Research
Fauci is out...but his wife Christine Grady isn't nor his minions who he groomed there.
"While Grady’s work during the pandemic was described as “invaluable” by then-NIH director Francis Collins, the general public knows little about her day-to-day responsibilities.
An open records request for Grady’s job description reveals she, too, is meant to use her position to influence policy."
Christine Grady, Ph.D., chief of the Department of Bioethics of the National Institutes of Health (NIH) Clinical Center.
SPAC or no SPAC...Science will win.
GLTA
You should follow Khalpey on twitter and Linkedin...lots of good information there. Also read the PR of the Khalpey and BGEN partnership, the articles in the Yuan, and the Biogenysis website for synergies that can be found.
Last time patents was tweeted that I can see was 3 days ago...since then it's been the interaction between Khalpey and Dr Chandra talking AI which intrigues many on how that partnership plays out.
September I believe was the last time he used the #SAGA, when he linked the SAGA PR. Since September i have seen #AI, ENZC, #BGEN, #Assetbuilding #ENZCStrong #ChandraDrishti as far as Company focused tweets.
That's the whole thing about investing...you have to wait to get those answers.
The PIPE investments mentioned in the PRs and also in the lawsuits is where funding for animal studies will come from. $450M was the value of the subs that SAGA placed and in return issued 45M shares to Enzolytics.
Keeping your ENZC shares while in addition one receives a special dividend in Nasdaq shares of SAGA, is not a R/S in any stretch.
Well FDA delayed the release of IPF 8 months...which changed things. Harry and Diane took over IPF with VIRO and on their own. So at the time, after ECRM they had lots of interested retailers but FDA delay after soft launch seem to slow a lot of that. Fact is many of the ppl who complain about 27 retailers are the same ones who said IPF would never make it to market...well it did, and has been awesome for those who take the supplement. Harry finally seems to have an IPF Immune marketing plan as we have seen something with a new website and Tiki Barber getting behind the product. Fact is things are moving forward, sometimes slower or a different path we would think...but still headed to the milestones they have laid out. I have more family starting IPF this winter and hope others will too. I think it could be a big hit, but nobody invested on IPF Immune. I'm just glad it's available and made the doubters look dumb, but they just move to the next item as they did with audits (though many still pretend that didn't happen either).
Think this is my last post, cause ihub.
GLTA.
"The milestones we have set include the following:"
So they have a milestone, which was and always been known of taking Clone 3 to animal studies.
Now they also laid out that audits were a milestone to secure funding which then they would begin animal studies...well audits done end of 2022 and SPAC deal April 2023 announced...seems they are following the road map that has been shared over the past few years...
Yes, animal studies should be around 6 months, and later interview after that April 2021 PR you quoted (Hicks part 3 ~July 2021) and PRs (2021/2022) Charles stated they would do the animal studies in Europe. Which shows they pivoted away from the US along time ago so that hasn't been relevant since all latest progress has stated as such.
When were animal studies for mAbs funded? And by who?
In late 2021, they partnered with Samsung Biologics to produce their recombinant Clone 3 mAb in the CHO Cell Line, which they have and completed efficacy testing on them. The old auditors caused additional delays in their plans, by almost a year by never delivering anything that the Company had to fire and replace them ~ summer 2022 and the 2020 and 2021 audited fins were completed Dec 2022.
April 2023 the SPAC deal was announced and then the 2022 fins were audited and posted last month.
Despite the roadblocks put in their way, they continue progressing, which of course is frustrating, but that is life.
You seem like a mRNA injected person...good luck with that technology.
That potential is still real...animal studies is the milestone the Company has to reach, which is why the SPAC and Pipe investors are the last step (funding) to reach that milestone.